Amir Avniel
Presidente en BEYOND AIR, INC. .
Fortuna: 514 682 $ al 30/04/2024
Perfil
Amir Avniel is the founder of Beyond Air Ltd.
(founded in 2011) and Ait Ltd.
(founded in 2011).
He holds the title of Chief Business Officer at Beyond Air Ltd.
and Chief Executive Officer & Director at Ait Ltd.
Mr. Avniel's current job(s) include being the President, Director & Chief Business Officer at Beyond Air, Inc. (since 2017) and the Executive Director at Beyond Cancer, Ltd.
Mr. Avniel's former job(s) include being the President & Chief Executive Officer at Rosetta Genomics Ltd.
(2006-2009), President & Chief Executive Officer at G.F.C Green Fields Capital Ltd.
(2010-2013), Chairman at Enox Biopharma, Inc., and Head-Strategy & Business Development at AB Seeds Ltd.
(2013-2014).
Mr. Avniel's education history includes completing an undergraduate degree at The Open University of Israel.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BEYOND AIR, INC.
0.95% | 20/03/2024 | 438 027 ( 0.95% ) | 514 682 $ | 30/04/2024 |
Cargos activos de Amir Avniel
| Empresas | Cargo | Inicio |
|---|---|---|
| BEYOND AIR, INC. | Presidente | 13/01/2017 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Fundador | 01/05/2011 |
Ait Ltd.
 Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011. | Fundador | 01/01/2011 |
Beyond Cancer, Ltd.
 Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Amir Avniel.
| Empresas | Cargo | Fin |
|---|---|---|
| AB Seeds Ltd. | Corporate Officer/Principal | 01/01/2014 |
| G.F.C GREEN FIELDS CAPITAL LTD. | Director Ejecutivo | 01/01/2013 |
| ROSETTA GENOMICS LTD. | Director Ejecutivo | 01/01/2009 |
Enox Biopharma, Inc.
 Enox Biopharma, Inc. Medical SpecialtiesHealth Technology Enox Biopharma, Inc. operated in the development of Develops antimicrobial medical devices coated with Nitric Oxide. It products include urinary catheters, endotracheal tubes, central venous lines and other short term indwelling devices. The company was founded by Yossef Av-Gay on June 27, 2007 and is headquartered in Yehud-Monosson, Israel. | Presidente | - |
Formación de Amir Avniel.
| The Open University of Israel | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ROSETTA GENOMICS LTD. | Health Technology |
| G.F.C GREEN FIELDS CAPITAL LTD. | Finance |
| BEYOND AIR, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Enox Biopharma, Inc.
Enox Biopharma, Inc. Medical SpecialtiesHealth Technology Enox Biopharma, Inc. operated in the development of Develops antimicrobial medical devices coated with Nitric Oxide. It products include urinary catheters, endotracheal tubes, central venous lines and other short term indwelling devices. The company was founded by Yossef Av-Gay on June 27, 2007 and is headquartered in Yehud-Monosson, Israel. | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011. | Health Technology |
Beyond Cancer, Ltd.
Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Health Technology |
| AB Seeds Ltd. |
- Bolsa de valores
- Insiders
- Amir Avniel
